Skip to main content
. Author manuscript; available in PMC: 2019 Oct 30.
Published in final edited form as: Clin Cancer Res. 2019 Jul 15;25(19):5752–5758. doi: 10.1158/1078-0432.CCR-18-3453

Figure 2. Phospho-tyrosine 1289-ErbB3 Expression by VeraTag®.

Figure 2.

(A) Change in pErbB3 level in individual patient tumor samples. Post-treatment pErbB3 levels were below the assay level of detection for four patients (108–01, 110–02, 111–02 and 112–02); values were set at the assay level of detection of 0.14. (B) Mean tumor pErbB3 levels for all patients (n=12) before and after CDX-3379 treatment.